|
|
| Línea 1: |
Línea 1: |
| ==Administration==
| | #REDIRECT[[Hydromorphone]] |
| *Type: [[Opiods]]
| |
| *Routes of Administration: Oral, IM, IV, PCA
| |
| *Common Trade Names: Hydromorphone
| |
| | |
| ==Adult Dosing==
| |
| *Oral: 2-4 mg PO q4-6h PRN
| |
| *IV: 0.2-1 mg IV q2-3h PRN
| |
| *IM: 1-2 mg IM q2-3h PRN (not recommended secondary to variable absorption)
| |
| | |
| ==Pediatric Dosing==
| |
| | |
| ==Special Populations==
| |
| *[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
| |
| *[[Lactation risk categories|Lactation risk]]:
| |
| ===Renal Dosing===
| |
| *Adult:
| |
| *Pediatric:
| |
| ===Hepatic Dosing===
| |
| *Adult:
| |
| *Pediatric:
| |
| | |
| ==Contraindications==
| |
| *Allergy to class/drug
| |
| | |
| ==Adverse Reactions==
| |
| ===Serious===
| |
| | |
| ===Common===
| |
| | |
| ==Pharmacology==
| |
| *Half-life:
| |
| *Metabolism:
| |
| *Excretion:
| |
| | |
| ==Mechanism of Action==
| |
| | |
| ==Comments==
| |
| | |
| ==See Also==
| |
| | |
| ==References==
| |
| <references/>
| |
| [[Category:Pharmacology]]
| |
